CN1739522A - 一种别嘌醇缓释片剂及其制备方法 - Google Patents
一种别嘌醇缓释片剂及其制备方法 Download PDFInfo
- Publication number
- CN1739522A CN1739522A CN 200410093148 CN200410093148A CN1739522A CN 1739522 A CN1739522 A CN 1739522A CN 200410093148 CN200410093148 CN 200410093148 CN 200410093148 A CN200410093148 A CN 200410093148A CN 1739522 A CN1739522 A CN 1739522A
- Authority
- CN
- China
- Prior art keywords
- allopurinol
- slow releasing
- tablet
- releasing tablet
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 229960003459 allopurinol Drugs 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000003085 diluting agent Substances 0.000 claims abstract description 9
- 239000011159 matrix material Substances 0.000 claims abstract description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- -1 hydroxypropyl Chemical group 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 238000013268 sustained release Methods 0.000 claims description 8
- 239000012730 sustained-release form Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000004203 carnauba wax Substances 0.000 claims description 2
- 229960000913 crospovidone Drugs 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229960004667 ethyl cellulose Drugs 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229950005770 hyprolose Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HXNFUBHNUDHIGC-UHFFFAOYSA-N oxypurinol Chemical group O=C1NC(=O)N=C2NNC=C21 HXNFUBHNUDHIGC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000003064 xanthine oxidase inhibitor Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
时间(小时) | 1 | 2 | 4 | 6 | 8 |
溶出 | 25 | 40 | 60 | 70 | 90 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100931480A CN100500155C (zh) | 2004-12-17 | 2004-12-17 | 一种别嘌醇缓释片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100931480A CN100500155C (zh) | 2004-12-17 | 2004-12-17 | 一种别嘌醇缓释片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1739522A true CN1739522A (zh) | 2006-03-01 |
CN100500155C CN100500155C (zh) | 2009-06-17 |
Family
ID=36092147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100931480A Active CN100500155C (zh) | 2004-12-17 | 2004-12-17 | 一种别嘌醇缓释片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100500155C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102406619A (zh) * | 2011-11-29 | 2012-04-11 | 北京科信必成医药科技发展有限公司 | 一种缓释微丸及其制备方法 |
CN102440963A (zh) * | 2011-11-29 | 2012-05-09 | 北京科信必成医药科技发展有限公司 | 一种别嘌醇缓释微丸及其制备方法 |
CN102579384A (zh) * | 2011-01-17 | 2012-07-18 | 杭州赛利药物研究所有限公司 | 别嘌醇缓释微丸片及其制备方法 |
CN102091051B (zh) * | 2009-12-14 | 2013-01-23 | 北京科信必成医药科技发展有限公司 | 一种别嘌醇双释放制剂及其制备方法 |
CN103142602A (zh) * | 2013-03-15 | 2013-06-12 | 汤日波 | 别嘌呤醇在制备用于房颤导管消融术后药物中的应用 |
CN104288127A (zh) * | 2014-11-04 | 2015-01-21 | 周有财 | 一种别嘌醇缓释胶囊及其制备方法 |
CN104306340A (zh) * | 2014-10-27 | 2015-01-28 | 哈尔滨商业大学 | 一种别嘌醇缓控释微粒及其制备方法 |
CN101808643B (zh) * | 2007-06-19 | 2015-09-09 | 文森特·巴克曼 | 用于治疗马科动物蹄叶炎的制剂 |
CN103127022B (zh) * | 2011-11-23 | 2017-08-18 | 常州善美药物研究开发中心有限公司 | 一种别嘌醇复合型释药系统及其制备方法 |
CN113081989A (zh) * | 2021-03-29 | 2021-07-09 | 海南普利制药股份有限公司 | 别嘌醇缓释片剂 |
CN113318092A (zh) * | 2021-06-10 | 2021-08-31 | 黑龙江澳利达奈德制药有限公司 | 一种别嘌醇缓释胶囊 |
CN116270545A (zh) * | 2021-12-20 | 2023-06-23 | 燃点(南京)生物医药科技有限公司 | 一种别嘌醇缓释胶囊及制备方法 |
-
2004
- 2004-12-17 CN CNB2004100931480A patent/CN100500155C/zh active Active
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101808643B (zh) * | 2007-06-19 | 2015-09-09 | 文森特·巴克曼 | 用于治疗马科动物蹄叶炎的制剂 |
CN102091051B (zh) * | 2009-12-14 | 2013-01-23 | 北京科信必成医药科技发展有限公司 | 一种别嘌醇双释放制剂及其制备方法 |
CN102579384B (zh) * | 2011-01-17 | 2015-09-02 | 杭州赛利药物研究所有限公司 | 别嘌醇缓释微丸片及其制备方法 |
CN102579384A (zh) * | 2011-01-17 | 2012-07-18 | 杭州赛利药物研究所有限公司 | 别嘌醇缓释微丸片及其制备方法 |
CN103127022B (zh) * | 2011-11-23 | 2017-08-18 | 常州善美药物研究开发中心有限公司 | 一种别嘌醇复合型释药系统及其制备方法 |
CN102440963A (zh) * | 2011-11-29 | 2012-05-09 | 北京科信必成医药科技发展有限公司 | 一种别嘌醇缓释微丸及其制备方法 |
CN102406619A (zh) * | 2011-11-29 | 2012-04-11 | 北京科信必成医药科技发展有限公司 | 一种缓释微丸及其制备方法 |
CN103142602B (zh) * | 2013-03-15 | 2014-12-10 | 汤日波 | 别嘌呤醇在制备用于房颤导管消融术后药物中的应用 |
CN103142602A (zh) * | 2013-03-15 | 2013-06-12 | 汤日波 | 别嘌呤醇在制备用于房颤导管消融术后药物中的应用 |
CN104306340A (zh) * | 2014-10-27 | 2015-01-28 | 哈尔滨商业大学 | 一种别嘌醇缓控释微粒及其制备方法 |
CN104306340B (zh) * | 2014-10-27 | 2017-07-04 | 哈尔滨商业大学 | 一种别嘌醇缓控释微粒及其制备方法 |
CN104288127A (zh) * | 2014-11-04 | 2015-01-21 | 周有财 | 一种别嘌醇缓释胶囊及其制备方法 |
CN113081989A (zh) * | 2021-03-29 | 2021-07-09 | 海南普利制药股份有限公司 | 别嘌醇缓释片剂 |
CN113318092A (zh) * | 2021-06-10 | 2021-08-31 | 黑龙江澳利达奈德制药有限公司 | 一种别嘌醇缓释胶囊 |
CN116270545A (zh) * | 2021-12-20 | 2023-06-23 | 燃点(南京)生物医药科技有限公司 | 一种别嘌醇缓释胶囊及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100500155C (zh) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1245158C (zh) | 片剂组合物 | |
CN1739522A (zh) | 一种别嘌醇缓释片剂及其制备方法 | |
WO2017114227A1 (zh) | 一种复方达格列净二甲双胍缓释片及其制备方法 | |
PL187761B1 (pl) | Sposób wytwarzania antybiotyku beta-laktamowego, aglomeraty antybiotyku beta-laktamowego, mieszanina aglomeratów antybiotyku beta-laktamowego i drugiej substancji farmakologicznie czynnej, zastosowanie aglomeratów antybiotyku beta-laktamowego oraz tabletka zawierająca antybiotyk beta-laktamowy | |
US20110091547A1 (en) | Pharmaceutical Compositions Comprising Brivaracetam | |
CN114848604A (zh) | 一种恩格列净和盐酸二甲双胍复方制剂及其制备方法 | |
CN104055743B (zh) | 一种含利伐沙班口服制剂的制备方法 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
CN105078974A (zh) | 一种阿利沙坦酯固体分散体及药物组合物 | |
CN112315918B (zh) | 一种替格瑞洛药物制剂 | |
CN1700910A (zh) | 甲福明控释片剂 | |
CN1709253A (zh) | 一种含匹伐他汀的稳定的药物组合物 | |
CN107753455B (zh) | 一种含有咪达那新的片剂及其制备方法 | |
CN104337787A (zh) | 含有利伐沙班的药物制剂 | |
US20060147519A1 (en) | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets | |
CN101066255A (zh) | 乌苯美司薄膜衣片 | |
CN103127022A (zh) | 一种别嘌醇复合型释药系统及其制备方法 | |
CN104940204A (zh) | 一种替格瑞洛固体制剂及其制备方法 | |
CN1241568C (zh) | 复方氨酚那敏缓释片和制备方法 | |
CN1742730A (zh) | 高溶出度的盐酸二甲双胍格列吡嗪胶囊的制备方法 | |
CN1077888A (zh) | 阿糖胞苷十八烷基磷酸盐硬胶囊 | |
CN113712929A (zh) | 一种mt-1207盐酸盐缓释制剂及其制备方法与应用 | |
CN1839835A (zh) | 一种拉西地平药物制剂的制备方法 | |
CN106983728B (zh) | 普拉克索缓释片及制备方法 | |
CN1842333A (zh) | 口服缓释片剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN POLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: FAN MINHUA Effective date: 20100707 Owner name: ZHEJIANG RUIDA PHARMACEUTICAL CO., LTD. HANGZHOU S |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310009 HOUSE 6, JINTAI BUSINESS BUILDING, NO.571, QINGTAI STREET, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 571127 GUILINYANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, MEILAN DISTRICT, HAIKOU CITY, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100707 Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Co-patentee after: Zhejiang Ruida Pharmaceutical Co.,Ltd. Patentee after: Hainan Poly Pharm Co.,Ltd. Co-patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 310009, 6 building, Jintai business building, 571 Tai Ching street, Zhejiang, Hangzhou Patentee before: Fan Minhua |
|
CI01 | Publication of corrected invention patent application |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Volume: 26 |
|
CI03 | Correction of invention patent |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Page: The title page Volume: 26 |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee after: HAINAN POLY PHARM. Co.,Ltd. Patentee after: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee before: Hainan Poly Pharm Co.,Ltd. Patentee before: Zhejiang Ruida Pharm Co.,Ltd. Patentee before: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230111 Address after: 571127 Guilin Ocean Economic Development Zone, Meilan District, Haikou City, Hainan Province Patentee after: HAINAN POLY PHARM. Co.,Ltd. Patentee after: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Address before: 571127 Guilin Ocean Economic and Technological Development Zone, Meilan District, Haikou City, Hainan Province Patentee before: HAINAN POLY PHARM. Co.,Ltd. Patentee before: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee before: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice |
Addressee: Zhu Xulei Document name: Notification of Conformity |
|
DD01 | Delivery of document by public notice |